Hyperlipidemia, Familial CombinedHyperlipidemiasHypertensionHypertension, PulmonaryTriglyceridesHypolipidemic AgentsLipidsCholesterolBlood PressureHypertension, RenalHypertension, PortalAntihypertensive AgentsRisk FactorsHypertriglyceridemiaCholesterol, LDLHypertension, RenovascularHypercholesterolemiaHyperlipoproteinemia Type IVLipoproteinsApolipoproteins EHypertension, MalignantLipid MetabolismCholesterol, HDLApolipoproteins BApolipoproteins CApolipoprotein E2ObesityApolipoprotein C-IIIFenofibrateLipoprotein LipaseArteriosclerosisXanthomatosisLipoproteins, VLDLAnticholesteremic AgentsDiabetes MellitusHydroxymethylglutaryl-CoA Reductase InhibitorsLiverCardiovascular DiseasesApolipoproteinsLipoproteins, LDLDisease Models, AnimalCholesterol, VLDLAtherosclerosisDietary FatsGynostemmaBody WeightHyperlipoproteinemia Type IIHypertension, Pregnancy-InducedReceptors, LDLBlood GlucoseDiabetes Mellitus, Type 2DyslipidemiasPrevalenceInsulin ResistanceHyperlipoproteinemia Type IIITime FactorsMice, Inbred C57BLKidneyPoloxamerHeptanoic AcidsTreatment OutcomeDiet, AtherogenicOcular HypertensionApolipoprotein A-IPulmonary ArteryRats, Sprague-DawleyCholesterol, DietaryDiabetes ComplicationsAge FactorsRetrospective StudiesInsulinFatty LiverPostprandial PeriodSimvastatinBezafibratePyrrolesMice, KnockoutEpichlorohydrinRats, Inbred SHRFollow-Up StudiesApolipoproteins AProspective StudiesReninNephrotic SyndromeHyperlipoproteinemiasAortaIntracranial HypertensionSex FactorsBlood Pressure DeterminationDietBody Mass IndexRisk AssessmentProteinuriaHyperlipoproteinemia Type VCross-Sectional StudiesHyperglycemiaJapanCoronary DiseaseCohort StudiesMetabolic Syndrome X